Epidermal growth factor receptor (EGFR); insulin-like growth factor-1 receptor (IGF1R; CD221) BriefCommunication Pages: 731 - 731
Epidermal growth factor receptor (EGFR); tumor necrosis factor receptor superfamily member 9 (TNFRSF9; 4-1BB; CD137) BriefCommunication Pages: 732 - 732
S100 calcium binding protein A8 (S100A8; calgranulin A; MRP8); S100A9 (calgranulin B; MRP14) BriefCommunication Pages: 733 - 733
Guanosine 5′-diphosphate 3′-diphosphate (ppGpp); guanosine 5′-triphosphate 3′-diphosphate (pppGpp) BriefCommunication Pages: 738 - 738
Basigin Ok blood group (BSG; EMMPRIN; CD147); Neisseria meningitidis type IV pilus assembly protein (pilV); N. meningitidis major pilin PilE (pilE) BriefCommunication Pages: 740 - 740
Inducible nitric oxide synthase 2 (NOS2; iNOS); JAK kinase (JAK); signal transducer and activator of transcription 1 (STAT1) BriefCommunication Pages: 743 - 743
IL-21; inducible T cell co-stimulator (ICOS); CD40; CXC chemokine receptor 5 (CXCR5) BriefCommunication Pages: 746 - 746
Ex vivo GI organoids to model cancer progression and evaluate driver genes BriefCommunication Pages: 747 - 747
Crystal structure of the prokaryotic NavM sodium channel to model human Nav1.1 (SCN1A) BriefCommunication Pages: 748 - 748
Generation of human induced pluripotent stem (iPS) cell–derived retinal progenitor cells BriefCommunication Pages: 749 - 749
Near-infrared (IR)-based amplification of antibody-functionalized, chemotherapy-loaded nanocarriers plus radiation therapy (quadripeutics) to treat aggressive, therapy-resistant cancer BriefCommunication Pages: 751 - 751
